Published in Front Neurosci on July 23, 2015
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (2006) 8.15
Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci (1991) 5.71
Astrocyte activation and reactive gliosis. Glia (2005) 5.46
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng (2001) 4.64
Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron (1997) 4.49
Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci (1998) 4.19
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A (1997) 3.47
A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18
Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res (2005) 2.67
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (1999) 2.58
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell (2010) 2.46
Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci (2004) 2.24
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol (2004) 2.15
Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci (2002) 1.94
Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Exp Neurol (2002) 1.89
Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int J Biochem Cell Biol (2008) 1.78
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med (2004) 1.65
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem (2000) 1.60
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res (1990) 1.60
Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res (2007) 1.54
Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci (2000) 1.50
Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem (1994) 1.46
Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res (1997) 1.46
Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (1990) 1.43
Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging (2002) 1.39
Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med (2001) 1.35
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med (2002) 1.34
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging (2001) 1.31
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res (1992) 1.30
Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect (1990) 1.27
Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem (2006) 1.26
Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J Biol Chem (2002) 1.25
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia (2008) 1.21
Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol (2005) 1.19
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging (2009) 1.18
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol (2004) 1.18
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal (2000) 1.17
Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol (1989) 1.15
Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem Int (2001) 1.15
Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res (2003) 1.13
Metallostasis in Alzheimer's disease. Free Radic Biol Med (2012) 1.13
PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J Neurosci (2003) 1.08
Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J Neurosci Res (1991) 1.06
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis (2008) 1.00
Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met Ions Biol Syst (1999) 1.00
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans (2008) 0.99
Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2005) 0.99
Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res (1994) 0.99
Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol (2000) 0.99
The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res (1986) 0.98
Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol (2003) 0.96
Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry (2009) 0.96
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Neurobiol Aging (2012) 0.95
Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem (1995) 0.94
The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci (2009) 0.94
Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. Brain Res (2008) 0.94
Redox cycling of iron by Abeta42. Free Radic Biol Med (2005) 0.94
Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J Alzheimers Dis (2012) 0.91
Alzheimer's disease pathogenesis: role of aging. Ann N Y Acad Sci (2006) 0.91
Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage (2010) 0.87
Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Chem Res Toxicol (1997) 0.87
Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging. Neurobiol Aging (2007) 0.86
Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system? Biol Res (2001) 0.86
Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem Int (2012) 0.86
β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One (2014) 0.82
Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface. Biochemistry (2008) 0.82
H and L ferritin subunit mRNA expression differs in brains of control and iron-deficient rats. J Nutr (2002) 0.82
Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment. Transl Psychiatry (2013) 0.82
Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. Curr Med Imaging Rev (2011) 0.81
Ceruloplasmin and β-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron. Free Radic Biol Med (2014) 0.81
Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators. BMC Neurosci (2008) 0.80
In vivo magnetic resonance imaging of amyloid-β plaques in mice. Methods Mol Biol (2012) 0.80
Ferritin levels in microglia depend upon activation: modulation by reactive oxygen species. Biochim Biophys Acta (2006) 0.79
Development of transferrin-positive oligodendrocytes in the rat central nervous system. J Neurosci Res (1987) 0.78
Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance. Curr Transl Geriatr Exp Gerontol Rep (2012) 0.78
Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration. Biomed Spectrosc Imaging (2013) 0.77
Expression of ferritin, transferrin receptor, and non-specific resistance associated macrophage proteins 1 and 2 (Nramp1 and Nramp2) in the human rheumatoid synovium. Ann Rheum Dis (2002) 0.77
Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation. Front Pharmacol (2013) 0.76